chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US00552 is an initial spontaneous report received from a nurse on 01 Aug 2011. This report refers to an adult female patient. She was given only the MenA powder conjugate component of MENVEO (batch number: A10053) reconstituted with a sterile diluent instead of MenCWY liquid conjugate component, intramuscularly on an unknown date. No other adverse reaction was reported.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US01363 is an initial spontaneous report received from health care professional on 11 Aug 2011. This report refers to a patient of an unknown age and gender. The patient was vaccinated with MENVEO (batch number: unknown) on unspecified date. But, the patient received only the Men CWY liquid conjugate without reconstituting it with the Men A lyophilized powder component. No adverse reaction had occurred following this drug administration error.
Age: 15.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US01521 is an initial spontaneous report received from health care professional on 12 Aug 2011. This report refers to a 15 years old male patient. He was vaccinated with MENVEO (batch number: 090601A) 0.5 ml intramuscularly on 04 Aug 2011. But, he received only the Men CWY liquid conjugate without reconstituting it with the Men A lyophilized powder component. No adverse reaction had occurred following this drug administration error.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Case number PHEH2011US01891 is an initial spontaneous report received from a health care professional (medical assistant)on 17 Aug 2011. This report refers to a 12 year old male patient. He was vaccinated with MENVEO 0.5 ml, intramuscularly on 17 Aug 2011, which was stored out of range temperature during shipment on 17 Aug 2011. No adverse event was reported following the vaccination.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Case number PHEH2011US01888 is an initial spontaneous report received from a health care professional (medical assistant) on 17 Aug 2011. This report refers to a 12 year old female patient. She was vaccinated with MENVEO (batch number: A10062/X10062) 0.5 ml, intramuscularly on 17 Aug 2011, which was stored out of range temperature during shipment on 17 Aug 2011. No adverse event was reported following the vaccination.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Case number PHEH2011US01835 is an initial consumer report received on 17 Aug 2011. This report refers to 2 patients who were vaccinated with only Men CYW-135 liquid conjugate of MENVEO (batch number: unknown) intramuscularly, without reconstituting with Men A lyophilized powder component.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US01810 is an initial spontaneous report received from consumer on 10 Aug 2011. This report refers to a 15 years old female patient. She was vaccinated with MENVEO (batch number: A100051) intramuscularly on 08 Aug 2011. But, she received Men A lyophilized powder component which was reconstituted with sterile water instead of Men CWY liquid conjugate. No adverse reaction had occurred following this drug administration error.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US01756 is an initial spontaneous report received from a health care professional on 03 Aug 2011. This report refers to an adolescent female patient. She was given only the MenA powder conjugate component of MENVEO (batch number: A10059 and expiry date: Jan 2013) reconstituted with a sterile diluent instead of MenCWY liquid conjugate component intramuscularly on 13 Jul 2011. No other adverse reaction was reported.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US01730 is an initial spontaneous report received from a health care professional (nurse) on 15 Aug 2011. This report refers to an 11 year old female patient. She was vaccinated with MENVEO (batch number: M10058) intramuscularly on 12 Aug 2011. But, she was only vaccinated with only the Men CYW-135 liquid conjugate without reconstituting it with Men A lyophilized  powder content. No adverse event was reported following this drug administration error.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US01626 is an initial spontaneous report received from a health care professional (medical assistant) on 10 Aug 2011. This report refers to an adult male patient. He was vaccinated with MENVEO (batch number A10052, expiry date: Jan 2013) intramuscularly on unspecified date. But, the patient received only the Men CYW-135 liquid conjugate component which was not reconstituted with Men A lyophilized powder component. No adverse reaction was reported following this drug administration error.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US01749 is an initial spontaneous report received from a health care professional on 02 Aug 2011. This report refers to an 18 years old female patient. She was given only the MenCWY liquid conjugate component of MENVEO (batch number M10053) intramuscularly 02 Aug 2011. No other adverse reaction was reported.
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHEH2011US55982 is in initial spontaneous report received from a nurse on 20 Jun 2011 with a follow up from nurse received on 14 Jul 2011. This report refers to a 14 year old male patient. He was vaccinated with MENVEO (batch number: X100028) 0.5 ml, intramuscularly on 15 Jun 2011. The patient received only the Men CYW-135 liquid component without reconstituting it with Men A powder component. No adverse event was reported following this drug administration error. Follow up information on 14 Jul 2011: The patient demographics and vaccination details were updated.
Age: 19.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US60202 is an initial spontaneous report received from a registered nurse on 01 Jul 2011. This report refers to a 19 year old male patient. He was vaccinated with MENVEO (batch number: 090701) intramuscularly on 01 Jul 2011. But he received only Men CYW liquid component without reconstituting it with Men A powder component. No adverse events were reported following this drug administration error.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US60072 is a combined initial and follow-up spontaneous report received from a nurse on 08 Jul 2011 and 13 Jul 2011. This report refers to a 17 years old female patient. She was given only the CYW-135 liquid component of MENVEO (batch number: M10034) intramuscularly on 27 Jun 2011. She was also vaccinated with GARDASIL (batch number: 15692, other manufacturer) intramuscularly on the same day. No other adverse reaction was reported.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US56426 is an initial spontaneous report received from a nurse on 24 Jun 2011. This report refers to an 18 years old male patient. He was given only the MenCYW liquid conjugate component of MENVEO (batch number X10051) without being reconstituted with MenA lyophilised conjugate component, intramuscularly on 22 Jun 2011. No other adverse reaction was reported.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Case number PHHY2011US59051 is an initial spontaneous report received from a medical assistant on 30 Jun 2011. This report refers to a 17 year old male patient. He was vaccinated with MENVEO (batch number: A10032) intramuscularly on 30 Jun 2011. He received another dose of MENVEO (batch number: A10032) intramuscularly again by error on 30 Jun 2011. No adverse event was reported following this drug administration error.
Age: 21.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US58425 is an initial spontaneous report received from a consumer on 28 Jun 2011 with a follow-up from the consumer on 11 Jul 2011. This report refers to a 21 years old female patient. She was given only the CYW-135 liquid component of MENVEO (batch number: 090701) without being reconstituted with MenA lyophilized conjugate component, intramuscularly on 11 Jun 2011. The patient was revaccinated with the correctly reconstituted MENVEO (batch number: unknown) on 29 June 2011. No other adverse reaction was reported. Follow-up received from the consumer on 11 Jul 2011: Updated information about revaccination of the patient.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US57675 is an initial spontaneous report received from a nurse on 27 Jun 2011. This report refers to an 18 years old male patient. He was given only the MenA lyophilized conjugate component of MENVEO (batch number: unknown) reconstituted with sterile water instead of MenCYW liquid conjugate component, intramuscularly on an unspecified date. No other adverse reaction was reported.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Case number PHHY2011US61533 is an initial spontaneous report received from a consumer on 08 Jul 2011. This report refers to a patient of unspecified age and gender. The patient was vaccinated with only half a dose of MENVEO (batch number not provided) intramuscularly on unspecified date. No adverse event was reported following this under dose.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US60201 is an initial spontaneous report received from a physician on 05 Jul 2011. This report refers to an 11 year old boy. He was vaccinated with MENVEO (batch number: M10047) 0.5 ml, intramuscularly on unspecified date. But, the patient received 0.5 ml of only Men CYW-135 liquid conjugate without reconstituting it with Men A powder component. No adverse events were reported following this drug administration error.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US60076 is an initial spontaneous report received from a nurse practitioner on 05 Jul 2011 with a follow-up from the nurse on 25 Jul 2011. This report refers to a 12 year old female patient. She was vaccinated with MENVEO (batch number: M10047) 0.5 ml, intramuscularly on 20 Jun 2011. But the patient was administered Men A which was reconstituted with sterile water instead of men CYW-135 liquid component. On the same day she was also vaccinated with the booster dose of BOOSTERIX (other manufacturer) intramuscularly at a dose of 0.5 ml. No adverse event was reported following this drug administration error. Follow-up received from the nurse on 25 Jul 2011: Updated information about concomitant vaccination.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Case number PHHY2011US44954, is an initial report from a health care professional received on 25 May 2011. This report refers to a female child. The child received vaccination with MENVEO (batch number unknown) on 13 Apr 2011. The patient was administered only MenCYW-135 component (dilutant). No other information was reported.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US43957 is a spontaneous report received from a nurse initially on 19 May 2011 with a follow-up on 01 Jun 2011 and 07 Jun 2011. This report refers to a 17-year-old male patient. He was given only the CYW-135 liquid component MENVEO (batch number 091201, expiry date: Sep 2012) intramuscularly at right deltoid on 10 Mar 2011. The patient did not experienced any adverse event. Follow-up report received on 01 Jun 2011. Updated vaccination status. Follow-up report received on 07 Jun 2011. Updated site of vaccination and patient demographics.
Age: 13.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US45141 is an initial spontaneous report received from a health care professional (HCP) on 24 May 2011. This report refers to a 13 years old female patient. She was given only the MenA lyophilized component of MENVEO (batch number: 1000026) reconstituted with sterile saline, intramuscularly on 24 May 2011. No other adverse reaction was reported.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Rash erythematous
Clinical narrative: Case number PHEH2011US01199 is an initial spontaneous report received from a physician on 10 Aug 2011. This report refers to a 12 years old female patient. She was vaccinated with MENVEO (batch number: M10053) intramuscularly at a dose of 0.5 ml on 01 Aug 2011. On 03 Aug 2011 she developed a red rash on her neck and ears. Outcome of the event was unknown.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHEH2011US01200 is an initial spontaneous report received from a physician on 10 Aug 2011. This report refers to a 12 years old male patient. He was vaccinated with MENVEO (batch number: M10053) intramuscularly at a dose of 0.5 ml on 01 Aug 2011. On 03 Aug 2011 he developed a tennis ball sized raised, red, tender area at the injection site. Outcome of the event was unknown.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US69628 is an initial spontaneous report received from health care professional on 29 Jul 2011. This case refers to 11 year old male patient. He was vaccinated with MENVEO (batch number: M10034) 0.5ml intramuscularly on 28 Jul 2011. But, he was given only Men A conjugate conjugated vaccine reconstituted with a sterile diluent instead of Men CYW-135 liquid conjugate. No adverse reaction had occurred following this drug administration error.
Age: 27.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US69684 is an initial spontaneous report received from a nurse on 26 Jul 2011. This report refers to an adult male patient. He was given only the CYW-135 liquid component MENVEO (batch number 100053) intramuscularly on 20 Jul 2011. He was vaccinated with a complete reconstituted dose of MENVEO (batch number: 100053) on 21 Jul 2011 which was well tolerated. No other adverse reaction was reported.
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US69685 is an initial spontaneous report received from a health care professional on 28 Jul 2011. This report refers to a female patient of unknown age group. She was given only the CYW-135 liquid component of MENVEO (batch number: X10051 and expiry date: Jan 2013) intramuscularly on 21 Jul 2011. No other adverse reaction was reported.
Age: 51.0
Sex: M
Vaccine: MNQ
Symptoms: No adverse event, Underdose
Clinical narrative: Case number PHHY2011US69747 is an initial spontaneous report received from a nurse on 25 Jul 2011. This report refers to a 51 years old male patient. He was vaccinated with 0.4 ml (underdose) of MENVEO (batch number: A100053) intramuscularly on 11 Jul 2011. No other adverse event was reported.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness
Clinical narrative: Case number PHEH2011US01395 is an initial spontaneous report received from a nurse on 05 Aug 2011. This report refers to a 15 years old female patient. She was vaccinated with MENVEO (batch number: A10047) intramuscularly on an undetermined date. After vaccination she experienced lightheadedness. The reporter also had other patients, who experienced similar symptoms of lightheadedness and fainting after receiving other unspecified vaccines, but the reporter did not have details regarding any other patient or any other adverse event experienced. No further information was available.
Age: 28.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Case number PHEH2011US01543 is an initial spontaneous report received from a consumer on 11 Aug 2011. This report refers to a patient of unknown age group and gender. This patient was vaccinated with MENVEO (batch number: unknown) intramuscularly on 10 Aug 2011. Subsequently the patient experienced nausea, vomiting and headache. No further details were provided.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Headache
Clinical narrative: Case number PHHY2011US52502 is an initial spontaneous report received from a consumer on 13 Jun 2011. This report refers to an adolescent female patient. She was vaccinated with MENVEO (batch number: unknown) intramuscularly on 10 Jun 2011. Several hours after vaccination, she developed a headache. The headache became intense during the evening on 11 Jun 2011. Finally, the headache resolved on an undetermined date.
Age: 18.0
Sex: M
Vaccine: MNQ, UNK
Symptoms: Asthenia, Fatigue, Hypoaesthesia, Injection site erythema, Injection site pain
Clinical narrative: Case number PHEH2011US01170 is an initial spontaneous report received from a nurse on 05 Aug 2011. This report refers to an 18 years old male patient. He was vaccinated with MENVEO (batch number: A10047) intramuscularly on an unknown date. He was also vaccinated with three other unspecified vaccines on the same day as MENVEO but no information about these shots were provided. After vaccination he experienced redness, pain and swelling at the injection site which progressed to tingling in the fingers of the same arm and numbness in the same armpit, which later progressed to fatigue and weakness the next day. The reporter did not know if the reactions were related to MENVEO or other vaccines administered, since there were fainting and other similar types of reaction with other patients after other vaccinations. However, the reported did not have any specific details about any other patients that experienced reactions to other vaccines or the name of the vaccines. This event was also reported to vaccine adverse event reporting system (VAERS) website.
Age: 18.0
Sex: M
Vaccine: MNQ, UNK
Symptoms: Injection site swelling, Paraesthesia
Clinical narrative: Case number PHEH2011US01170 is an initial spontaneous report received from a nurse on 05 Aug 2011. This report refers to an 18 years old male patient. He was vaccinated with MENVEO (batch number: A10047) intramuscularly on an unknown date. He was also vaccinated with three other unspecified vaccines on the same day as MENVEO but no information about these shots were provided. After vaccination he experienced redness, pain and swelling at the injection site which progressed to tingling in the fingers of the same arm and numbness in the same armpit, which later progressed to fatigue and weakness the next day. The reporter did not know if the reactions were related to MENVEO or other vaccines administered, since there were fainting and other similar types of reaction with other patients after other vaccinations. However, the reported did not have any specific details about any other patients that experienced reactions to other vaccines or the name of the vaccines. This event was also reported to vaccine adverse event reporting system (VAERS) website.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHEH2011US01197 is a combined initial and follow-up spontaneous report received from a physician on 10 Aug 2011 and 16 Aug 2011. This report refers to a 17 years old female patient. She was vaccinated with MENVEO (batch number: M10059) intramuscularly at a dose of 0.5 ml on 08 Aug 2011. On 10 Aug 2011, she developed a silver dollar sized raised, red, tender area at the injection site. Outcome of the event was unknown.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US45143 is an initial spontaneous report received from a nurse on 20 May 2011 with follow-up on 01 Aug 2011. This report refers to an 11-year-old male patient. He was given only CYW-135 liquid component MENVEO (batch number M10034) intramuscularly on 05 May 2011. No other adverse reaction was reported. The patient was revaccinated. Follow-up received on 01 Aug 2011: Updated patient demographic and vaccination date.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Case number PHHY2011US45414, is a combined initial and follow-up reports from a nurse received on 25 May 2011 and 07 Jun 2011. This report refers to an 18-year-old female patient. The patient was vaccinated with MENVEO (batch number 090701) on 23 May 2011. The patient received only the MENVEO on 23 May 2011. No other information was reported.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Case number PHHY2011US45467 is an initial report received from a physician on 25 May 2011. This report refers to 2 patients who were vaccinated with MENVEO (batch number: unknown) intramuscularly. These patients received only the Mer A lyophilized conjugate component which was reconstituted with sterile diluent (instead of reconstituting it with Men CYW liquid conjugate).
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US69614 is an initial spontaneous report received from health care professional on 29 Jul 2011. This case refers to an 11 year old female patient. She was vaccinated with MENVEO (batch number: M10034) 0.5ml intramuscularly on 26 Jul 2011. But, she was given only Men A conjugate vaccine reconstituted with a sterile diluent instead of Men CYW-135 liquid conjugate. No adverse reaction had occurred following this drug administration error.
Sex: U
Vaccine: MNQ
Symptoms: Pyrexia
Clinical narrative: Case number PHEH2011US00881 is an initial spontaneous report received from a consumer on 01 August 2011. This report refers to a patient of unknown age group and gender. This patient was vaccinated with MENVEO vaccine (batch number: unknown) intramuscularly on an unknown date. After vaccination the patient experienced fever. No further information was available.
Age: 11.0
Sex: F
Vaccine: DTAP, MNQ
Symptoms: Injection site pain, Injection site rash, Sleep disorder
Clinical narrative: Case number PHEH2011US01314 is an initial spontaneous report received from a consumer on 09 Aug 2011. This report refers to an 11 years old female patient. She was vaccinated with MENVEO (batch number: unknown) intramuscularly on 08 Aug 2011. On the same day she was also vaccinated with DTaP in the same arm. After vaccination a bump developed at the injection site for both the vaccines. The bump at the MENVEO injection site was half inch in diameter and was painful. It was hurting all night and she could barely sleep last night. The reaction was still persisting.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Case number PHEH2011US01893 is an initial spontaneous report received from a health care professional (medical assistant) on 17 Aug 2011. This report refers to a 12 year old male patient. He was vaccinated with MENVEO (batch number: A10062/X10062) 0.5 ml, intramuscularly on 17 Aug 2011, which was stored out of of range temperature during shipment on 17 Aug 2011. No adverse event was reported following the vaccination.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US35447 is an initial report from a health care professional received on 25 Apr 2011 with a follow up from physician received on 28 Jun 2011: This report refers to multiple patients. Three patients received MENVEO (batch number A10027) intramuscularly on an unspecified date. These patients received MenCWY liquid conjugate component without reconstitution with MenA component. None of the patients experienced any adverse event.
Age: 23.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US37915 is an initial spontaneous report received from a health care professional on 03 May 2011 which combined an internal review on 13 May 2011 of the data received on 02 May 2011. The MRD of the initial report was wrongly reported as 03 May 2011 instead of 02 May 2011. This report refers to an adult male patient. He was given the lyophilized Men A component of MENVEO vaccine (batch number A100034) reconstituted with sterile water instead of the MenCYW conjugate component, intramuscularly on 28 Apr 2011. No other adverse reaction was reported. Following internal review on 13 May 2011 the MRD of the initial case was corrected.
Age: 18.0
Sex: F
Vaccine: DTAP, MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US40501 is an initial spontaneous report received from a health care professional (HCP) on 02 May 2011 with a follow up from HCP on 23 May 2011. This report refers to an 18 years old female patient. She was given the lyophilized Men A component of MENVEO vaccine (batch number A100034 and expiry date: Sep 2012) reconstituted with sterile water instead of the MenCYW conjugate component, intramuscularly into the right arm deltoid on 02 May 2011. On the same day, she was also vaccinated with DTaP vaccine (batch number: AC52130) into the left arm deltoid. No other adverse reaction was reported. Follow up information received from HCP on 23 May 2011: Updated information about patient's demographic concomitant medication and site of application of MENVO vaccine.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US43334 is an initial spontaneous report received from a nurse on 19 May 2011. This report refers to a 14 year old female patient. She was given only the CYW-135 liquid component MENVEO (batch number 090701) intramuscularly on 13 May 2011. No other adverse reaction was reported.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US43961 is an initial spontaneous report received from a nurse on 19 May 2011 with a combined follow up report received from nurse on 01 Jun 2011 and 07 Jun 2011. This report refers to a 19 year old female patient. She was given only the CYW-135 liquid component of MENVEO vaccine (batch number 091201, expiry date: Sep 2012) intramuscularly in the right arm deltoid on 26 Nov 2010. She came back alter and received the full dose. No other adverse reaction was reported. Combined follow up information received on 01 Jun 2011 and 07 Jun 2011: Further vaccination details were provided.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US44327 is an incomplete spontaneous report received from a nurse on 23 May 2011. This report refers to two patients whose age and gender were not specified. They were given only the MenA lyophilized component of MENVEO (batch number: unknown) reconstituted with another solution on an unspecified date. No other adverse reaction was reported.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US44843 is an initial report from a health care professional received on 04 May 2011. This report refers to 3-patients. These patients received MENVEO (batch number 100023). Three patient were inadvertently administered with only MenCYW-135 liquid conjugate component of MENVEO, the patient did not received the MenA lyophilized conjugate component. No adverse event occurred.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Case number PHHY2011US44949, is an initial report from a nurse received on 25 May 2011. This report refers to a 14-year-old female patient. The patient was vaccinated with MENVEO (batch number unknown) on 22 Apr 2011. Only Men ACY 135 component administered to the patient. No other information was reported.
Age: 2.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US63531 is an initial spontaneous report received from a physician on 14 Jul 2011. This report refers to a 2 year old boy. He was vaccinated with MENVEO (batch number: X1028) intramuscularly on 14 Jul 2011. But, the patient received only Men CYW-135 liquid conjugate without reconstituting it with Men A lyophilized powder conjugate. No adverse event was reported following this drug administration error.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US65527 is an initial spontaneous report received from a pharmacist on 19 Jul 2011 with a follow-up from the pharmacist on 04 Aug 2011. This report refers to an 18-year-old male patient. He was given only the MenCYW lyophilized liquid component of MENVEO (batch number: M100053) intramuscularly at a dose of 0.5 ml on 15 Jul 2011. No other adverse reaction was reported. Follow-up received from the pharmacist on 04 Aug 2011: Updated information about vaccination details.
Age: 12.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US66531 is an incomplete spontaneous report received from a nurse on 21 Jul 2011. This report refers to five patients of unknown age group and gender. They were given only the CYW-135 liquid component of MENVEO (batch number: unknown) intramuscularly on unknown dates. No other adverse event was reported.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US66794 is an initial spontaneous report received from a health care professional (nurse) on 21 Jul 2011 with a follow-up received from a nurse on 01 Aug 2011. This report refers to an 18 year old male patient. He was vaccinated with MENVEO (batch number: X10029) subcutaneously on 05 Jul 2011. But, he received only the Men A lyophilized powder component which was reconstituted with sterile water for diluent (instead of Men CYW-135 liquid conjugate). No adverse reaction was reported following this drug administration error. Follow-up received from a nurse on 01 Aug 2011: Updated information about patient's demographics, batch number and route of administration of MENVEO.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US67132 is an incomplete spontaneous report received from a healthcare professional on 19 Jul 2011. This report refers to multiple patients. They received only the CYW-135 liquid component of MENVEO (batch number: 100003 and 028011) intramuscularly on an unknown date. No other adverse event was reported.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US65527 is an initial spontaneous report received from a consumer on 20 Jul 2011. This report refers to a patient of unknown age group and gender. This patient was given only the MenCYW lyophilized liquid component of MENVEO (batch number: unknown) intramuscularly on an unspecified date. No other adverse reaction was reported.
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US68635 is an initial spontaneous report received from a health care professional on 28 Jul 2011. This report refers to a female patient of unknown age group. She was given only the MenA powder conjugate component of MENVEO (batch number: X10051 and expiry date: Jan 2013) reconstituted with a sterile diluent instead of MenCWY liquid conjugate component, intramuscularly on 21 Jul 2011. No other adverse reaction was reported.
Age: 23.0
Sex: F
Vaccine: MNQ
Symptoms: Accidental exposure, No adverse event
Clinical narrative: Case number PHHY2011US65543 is an initial spontaneous report received from a nurse on 19 Jul 2011. This report refers to a 23 years old female patient. She had accidentally squirted a small amount of MENVEO (batch number: X10051) into her eyes while drawing the vaccine in a syringe. No other adverse reaction was reported.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect dose administered
Clinical narrative: Case number PHHY2011US65594 is an initial spontaneous report received from a nurse on 20 Jul 2011. This report refers to unknown number of patients. These patients were vaccinated with MENVEO (batch number: unknown) intramuscularly at a dose more than recommended 0.5 ml of reconstituted vaccine.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Case number PHHY2011US65892 is an incomplete spontaneous report received from a nurse on 20 Jul 2011. This report refers to a group of patients. There were given only less than 0.5 ml dose of MENVEO (batch number: unknown) intramuscularly on unknown dates due to difficulty in withdrawing full dose after reconstitution. No other adverse reaction was reported.
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US65897 is an initial spontaneous report received from a health care professional (physician assistant) on 21 Jul 2011. This report refers to a 20 year old female patient. She was vaccinated with MENVEO (batch number: X10034) intramuscularly on 10 Jul 2011. But, the patient received only the Men CYW-135 liquid conjugate component without reconstituting it with Men A lyophilized powder component. No adverse reaction was reported following this drug administration error.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US63642 is an initial spontaneous report received from a nurse on 12 Jul 2011 with follow-up. This report refers to a 17 years old female patient. She was given only the MenA lyophilized conjugate component of MENVEO (batch number: A10034) 0.5 mL, reconstituted with sterile water instead of MenCYW liquid conjugate component, intramuscularly 11 Jul 2011. No other adverse reaction was reported. Patient was revaccinated with correct solution. Follow-up report received on 01 Aug 2011: Updated patient demographic and vaccination date.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US63990 is an initial spontaneous report received from a health care professional on 14 Jul 2011. This report refers to a 17 year old male patient. He was vaccinated with MENVEO (batch number: A10051) intramuscularly on 12 Jul 2011. The patient received only the Men CYW-135 liquid component without reconstituting it with Men A lyophilized powder component. No adverse event was reported following this drug administration error.
Age: 32.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect route of drug administration, No adverse event
Clinical narrative: Case number PHHY2011US63992 is an initial spontaneous report received from a health care professional (pharmacist) on 14 Jul 2011. This report refers to a 32 year old male patient. He was vaccinated with MENVEO (batch number: A00151, expiry date: Jan 2013) 0.5 ml, subcutaneously on 14 Jul 2011. No adverse reaction was reported following this incorrect route of administration.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US49117 is an initial spontaneous report received from a nurse on 02 Jun 2011. This report refers to a 13 year old boy. He was vaccinated with MENVEO (batch number: 090601A) intramuscularly on 02 Jun 2011. However, he was administered with only the Men CYW-135 liquid conjugate without reconstituting it with Men A powder component. No adverse event was reported following this drug administration error.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US49115 is an initial report from a health care professional received on 03 Jun 2011 with a follow up report received from health care professional on 21 Jun 2011. This report refers to an 18 year old male patient. He was vaccinated with MENVEO (batch number X10031) on 03 Jun 2011. He was administered 0.5 ml of only Men CYW-135 liquid conjugate without reconstituting it with Men A powder component. No adverse reaction occurred since this drug administration error.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US48972 is an initial spontaneous report received from a nurse on 02 Jun 2011. This report refers to 12 year old girl. She was vaccinated with MENVEO (batch number: 024011) 0.5 ml, intramuscularly on 01 Jun 2011. However, the Men A component was reconstituted with sterile water instead of Men CYW-135 liquid conjugate. No adverse event was reported following this drug administration error.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US47416 is an initial spontaneous report received from a health care professional (nurse) on 31 May 2011. This report refers to an 18 year old male patient. He was vaccinated with MENVEO (batch number 100001) intramuscularly on 31 Mar 2011. However, the patient was given only 0.5 ml of Men CYW liquid conjugate without reconstituting it with Men A powder component. No adverse events were reported following this drug administration error.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site urticaria, Rash macular
Clinical narrative: Itchy welts at the injection site/Red raised patches around injection site. Blotchy rash.
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US51502 is an initial spontaneous report received from a health care professional on 09 Jun 2011. This report refers to an adult male patient. He was given only the MenA lyophilized component of MENVEO (batch number: A10047) intramuscularly on 28 May 2011. He did not receive the MenCYW liquid conjugate component of the vaccine. No other adverse reaction was reported.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US69595 is an initial spontaneous report received from a health care professional on 28 Jul 2011. This report refers to an adolescent female patient. She was given only the CYW-135 liquid component MENVEO (batch number: M10053 and expiry date: Jan 2013) intramuscularly on 28 Jul 2011. No other adverse reaction was reported.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US61540 is an initial spontaneous report received from a medical assistant on 07 Jul 2011. This report refers to an 18 year old male patient. He was vaccinated with MENVEO (batch number: M10023) intramuscularly on 07 Jul 2011. But, the patient received Men A component which was reconstituted with sterile diluent instead of Men C, Y, W-135 liquid conjugate. No adverse event was reported following this drug administration error.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Case number PHHY2011US49518, is an initial spontaneous report from a nurse received on 25 May 2011. The patient was vaccinated with MENVEO (batch number 090701) on 23 May 2011. The patient received only the Men CYW-135 liquid vaccine component. No other information was reported.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US61987 is an initial up spontaneous report received from a nurse on 08 Jul 2011 and with the follow up report received on 09 Aug 2011. This report refers to a 12 years old female patient. Her concomitant medications included Tdap (batch number: AC52BD56B) 0.5 intramuscularly on 08 Jul 2011 and CLARITIN (batch number: unknown) on unspecified date. She was vaccinated with only the MenA lyophilized component of MENVEO (batch number M10047) reconstituted with sterile water instead of Men CYW liquid conjugate component 0.5ml to right arm intramuscularly on 08 Jul 2011. No other adverse reaction was reported. Follow up report received on 09 Aug 2011: The patient demographics, suspect drug information, concomitant medications and event outcome.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US55142 is an initial spontaneous report received from a consumer on 21 Jun 2011 with a follow up report from consumer received on 12 Jul 2011. This report refers to an 18 years old male patient. His medical history included unspecified allergies. He was given only the Men A lyophilized conjugate component of MENVEO (batch number A10031) 0.5 ml, intramuscularly in the left deltoid on 16 Jun 2011 which was reconstituted with sterile water instead of Men CYW-135 liquid conjugate component. No adverse reaction was reported following this drug administration error. Follow up information received on 12 Jul 2011: Patient demographics, medical history and vaccination details were updated.
Age: 17.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US55140 is an initial spontaneous report received from a health care professional on 21 Jun 2011. This report refers to an adolescent female patient. She was vaccinated with the MenA lyophilized component of MENVEO (batch number: 029011) which was inadvertently reconstituted with MENACTRA (batch number: U3466AA and expiry date: 17 Sep 2011) intramuscularly on 20 Jun 2011. No other adverse reaction was reported.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect storage of drug
Clinical narrative: Case number PHHY2011US52731 is an initial spontaneous report received from a health care professional (medical assistant) on 10 Jun 2011. This report refers to multiple patients who were vaccinated with MENVEO (batch number: 100023) intramuscularly, which was stored between 30 F and 35 F (outside recommended temperature range) for 30 days prior to vaccination.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US52728, is an initial report from a nurse received on 09 Jun 201 with a follow up report from health care professional received on 28 Jun 2011. This report refers to an 11-year-old female patient. She had a current condition of allergic rhinitis and concomitantly received treatment with ALLEGRA and NASONEX. The patient was vaccinated with MENVEO (batch number M10034) reconstituted with on 02 Jun 2011. She did not receive MenCYW-135 component. No adverse event occurred. Follow up report received on 28 Jun 2011. Patient demographics, medical history and concomitant medications were updated.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US69557 is an initial spontaneous report received from health care professional on 29 Jul 2011. This case refers to an 11 year old female patient. She was vaccinated with MENVEO (batch number: M10034) 0.5ml intramuscularly on 28 Jul 2011. But, she was given only Men A conjugate conjugated vaccine reconstituted with a sterile diluent instead of Men CYW-135 liquid conjugate. No adverse reaction had occurred following this drug administration error.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US49509 is an initial spontaneous report received from a nurse on 06 Jun 2011 with a combined follow-up received from the nurse on 05 Jul 2011 and 19 Jul 2011. This report refers to an adolescent female patient. She was given only the MenA lyophilized component of MENVEO (batch number M10049) intramuscularly at a dose of 0.5 ml into the left deltoid on 06 Jun 2011. The lyophilized powder was mixed with a regular sterile diluent instead of MenCYW liquid component of the vaccine. No other adverse reaction was reported. Combined follow-up received from the nurse on 05 Jul 2011 and 19 Jul 2011: Updated information about patient's demographics, site of administration and dose.
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US45969 is an initial spontaneous report received from a nurse on 26 May 2011. This report refers to a 20 year old female patient. She was vaccinated with MENVEO (batch number: 090901) intramuscularly on 26 May 2011. But, the patient received only Men CYW-135 liquid conjugate without reconstituting it with Men A component. No adverse event was reported following this error.
Age: 29.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect route of drug administration, No adverse event
Clinical narrative: Case number PHHY2011US63522 is an initial spontaneous report received from a health care professional (pharmacist) on 14 Jul 2011. This report refers to a 29 year old female patient. She was vaccinated with MENVEO (batch number: A00151, expiry date: Jan 2013) 0.5 ml, subcutaneously on 14 Jul 2011. No adverse reaction was reported following this incorrect route of administration.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US63382 is an initial spontaneous report received from a nurse on 12 Jul 2011: This report refers to an 11 year old male patient. He was vaccinated with MENVEO (batch number: X10028) 0.5 ml, intramuscularly on 27 Jun 2011. However, the patient received only the Men CYW liquid conjugate component without reconstituting it with Men A component. No adverse event was reported following this drug administration error.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US62732 is an initial spontaneous report received from a nurse on 12 Jul 2011. This report refers to an 11 year old boy. He was vaccinated with MENVEO (batch number: M10030) 0.5 ml, intramuscularly on 12 Jul 2011. However, the patient received only the Men CYW-135 liquid conjugate without reconstituting it with Men A powder conjugate. No adverse event was reported following this drug administration error.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Case number PHHY2011US64492 is an initial spontaneous report received from a health care professional (medical assistant) on 15 Jul 2011: This report refers to a 18 year old male patient. He was vaccinated with MENVEO (batch number: A10053) intramuscularly on 13 Jul 2011. But, the patient received only Men CYW-135 liquid conjugate without reconstituting it with Men A lyophilized powder conjugate. No adverse event was reported following this drug administration error.